TRIAL DETAIL

Study of XL820 in Adults With Solid Tumors

Drug:
Trial Name:
Study of XL820 in Adults With Solid Tumors
NCT#:
Conditions:
Cancer
Status:
Completed
Phase:
1
Start Date 08/01/2005
Age of Trial (yrs) 19.3
Treatment Phase:
Gleevec-resistant
Drug Category:
KIT/PDGFRA inhibitor
Strategy:
Block KIT
Trial Type:
GIST not specified. GIST patients known to be enrolled.
Other Protocol IDs:
XL820-001
Sponsor:
Exelixis
Patient Contact:
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral
Trial Notes:
We understand that the phase II trial for GIST has been "withdrawn".

Trial Links

Trial Results

Drug Information

The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
 

Trial Sites

Name
Address
City
State
Zip
Country
7979 Wurzbach Rd.
San Antonio
TX
78229
USA
195 Little Albany St.
New Brunswick
NJ
08903
USA